{"totalResults":33,"results":[{"description":"COVID-19 related research driven by a collaborative group of epidemiologists, geneticists, and data scientists to accelerate discovery around outcomes and risk factors for patients infected with SARS-CoV-2.","title":"COVID-19 Related Research in DCEG - National Cancer Institute","contentType":"cgvArticle","url":"https://dceg.cancer.gov/research/what-we-study/covid"},{"description":"COVID Mortality Tracker allows DCEG investigators to monitor weekly U.S. trends in overall and cause-specific mortality since the onset of the COVID-19 pandemic. The tools uses data visualization techniques to reveal patterns and generate potential research questions.","title":"COVID-19 Mortality Tracker - National Cancer Institute","contentType":"cgvArticle","url":"https://dceg.cancer.gov/research/how-we-study/descriptive-epidemiology/covid-mortality-tracker"},{"description":"Novel isoform of ACE2 (the cell receptor used by the SARS-CoV-2 virus to infect the body) identified. The new report suggests that production of ACE2 is not affected by the presence of interferons, contributed by treatment or various viral infections, including SARS-CoV-2.","title":"Novel Isoform of ACE2 Resolves Concern about Interferon-based Treatments for COVID-19 - National Cancer Institute","contentType":"cgvBlogPost","url":"https://dceg.cancer.gov/news-events/news/2020/ace2-covid"},{"description":"Sharon Savage, DCEG Clinical Director, describes the Division\u2019s COVID-19 research portfolio. DCEG investigators are applying their expertise in analyzing cancer incidence trends, assay development, germline genomics, and other techniques, to the study of COVID-19.","title":"COVID-era Research in DCEG: An Update from Sharon Savage, Clinical Director - National Cancer Institute","contentType":"cgvBlogPost","url":"https://dceg.cancer.gov/news-events/news/2020/covid-research-update"},{"description":"Genomic studies, serology assay valuation, descriptive epidemiology and other activities of DCEG investigators in response to the COVID-19 pandemic","title":"DCEG Experts Study the Global Pandemic - National Cancer Institute","contentType":"cgvBlogPost","url":"https://dceg.cancer.gov/news-events/news/2020/dceg-covid"},{"description":"The COVID-19 Seroprevalence Studies Hub (SeroHub) was developed by researchers at the Centers for Disease Control and Prevention (CDC), the National Cancer Institute, and the National Institute of Allergy and Infectious Diseases, to provide an interactive dashboard to compare COVID-19 seroprevalence studies across the country.","title":"COVID-19 Seroprevalence Studies Hub (SeroHub) - National Cancer Institute","contentType":"cgvArticle","url":"https://dceg.cancer.gov/research/what-we-study/serohub"},{"description":"The COVID-19 Seroprevalence Studies Hub (SeroHub) was developed by researchers at the Centers for Disease Control and Prevention (CDC), the National Cancer Institute, and the National Institute of Allergy and Infectious Diseases, to provide an interactive dashboard to compare COVID19 seroprevalence studies across the country.","title":"SeroHub Launched: Interactive Dashboard Comparing COVID-19 Seroprevalence Studies - National Cancer Institute","contentType":"cgvBlogPost","url":"https://dceg.cancer.gov/news-events/news/2020/serohub"},{"description":"Genome-wide association (GWAS) study and Whole Genome Sequencing (WGS) to identify common inherited factors associated with clinical outcomes for infection with COVID-19.","title":"COVNET: Large-scale Genome-wide Association Study and Whole Genome Sequencing of COVID-19 Severity - National Cancer Institute","contentType":"cgvArticle","url":"https://dceg.cancer.gov/research/how-we-study/genomic-studies/covnet"},{"description":"Version 2.5 - August 20, 2020","title":"Manual for Conducting a Large-scale GWAS and Whole Genome Sequencing (WGS) of COVID-19 infection","contentType":null,"url":"https://dceg.cancer.gov/research/how-we-study/genomic-studies/covnet-manual.pdf"},{"description":"Studies that investigate a range of exposures and risk factors for cancer","title":"What we study - exposures and risk factors for cancer - National Cancer Institute","contentType":"cgvMiniLanding","url":"https://dceg.cancer.gov/research/what-we-study"}]}